These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 11992132)

  • 1. Effects of the angiotensin receptor antagonist losartan on the response of the left main coronary artery to cold pressor test in patients with essential hypertension as assessed by echocardiography.
    Deng YB; Wang DW; Li CL; Yang HY
    Can J Cardiol; 2002 Apr; 18(4):389-96. PubMed ID: 11992132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin receptor antagonist losartan improves endothelial function of epicardial coronary arteries in patients with essential hypertension.
    Deng YB; Yang HY; Li CL; Chang Q
    Clin Cardiol; 2002 Sep; 25(9):422-8. PubMed ID: 12269521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new noninvasive method for evaluation of coronary endothelial function in hypertensive patients based on change in diameter of the left main coronary artery induced by cold pressor test using echocardiography.
    Deng YB; Wang XF; Li CL
    Clin Cardiol; 2001 Apr; 24(4):291-6. PubMed ID: 11303696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan.
    Schiffrin EL; Park JB; Intengan HD; Touyz RM
    Circulation; 2000 Apr; 101(14):1653-9. PubMed ID: 10758046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of fimasartan, a new angiotensin receptor blocker, compared with losartan (50/100 mg): a 12-week, phase III, multicenter, prospective, randomized, double-blind, parallel-group, dose escalation clinical trial with an optional 12-week extension phase in adult Korean patients with mild-to-moderate hypertension.
    Lee SE; Kim YJ; Lee HY; Yang HM; Park CG; Kim JJ; Kim SK; Rhee MY; Oh BH;
    Clin Ther; 2012 Mar; 34(3):552-568, 568.e1-9. PubMed ID: 22381711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin type 1 receptor antagonism reverses abnormal coronary vasomotion in atherosclerosis.
    Prasad A; Halcox JP; Waclawiw MA; Quyyumi AA
    J Am Coll Cardiol; 2001 Oct; 38(4):1089-95. PubMed ID: 11583887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time course of losartan blockade of angiotensin II hypertension versus blockade of angiotensin II fast pressor effects.
    Gorbea-Oppliger VJ; Melaragno MG; Potter GS; Petit RL; Fink GD
    J Pharmacol Exp Ther; 1994 Nov; 271(2):804-10. PubMed ID: 7965799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of an angiotensin II receptor blocker on the impaired function of endothelial progenitor cells in patients with essential hypertension.
    Suzuki R; Fukuda N; Katakawa M; Tsunemi A; Tahira Y; Matsumoto T; Ueno T; Soma M
    Am J Hypertens; 2014 May; 27(5):695-701. PubMed ID: 24200748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II type 1 receptor antagonist, losartan, causes regression of left ventricular hypertrophy in end-stage renal disease.
    Shibasaki Y; Masaki H; Nishiue T; Nishikawa M; Matsubara H; Iwasaka T
    Nephron; 2002 Mar; 90(3):256-61. PubMed ID: 11867945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antihypertensive effect of a non-peptide angiotensin II receptor antagonist, MK954, in patients with essential hypertension].
    Hagino T; Abe K; Tsunoda K; Yoshinaga K
    Nihon Jinzo Gakkai Shi; 1992 Feb; 34(2):133-40. PubMed ID: 1588765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin receptor blockade improves arterial distensibility and reduces exercise-induced pressor responses in obese hypertensive patients with the metabolic syndrome.
    Nashar K; Nguyen JP; Jesri A; Morrow JD; Egan BM
    Am J Hypertens; 2004 Jun; 17(6):477-82. PubMed ID: 15177518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of effect of angiotensin II receptor antagonist losartan on aortic distensibility in patients with essential hypertension by echocardiography.
    Yang H; Deng Y; Li C; Bi X; Pan M; Chang Q
    J Huazhong Univ Sci Technolog Med Sci; 2002; 22(2):164-7. PubMed ID: 12658764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial.
    Devereux RB; Dahlöf B; Gerdts E; Boman K; Nieminen MS; Papademetriou V; Rokkedal J; Harris KE; Edelman JM; Wachtell K
    Circulation; 2004 Sep; 110(11):1456-62. PubMed ID: 15326072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Angiotensin-II receptor inhibitors in hemodialysed uremia patients with arterial hypertension: candesartan cilexitil versus losartan].
    Cice G; Ferrara L; Tagliamonte E; Russo PE; Di Benedetto A; Iacono A
    Cardiologia; 1999 Dec; 44(12):1071-6. PubMed ID: 10687258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of losartan versus hydrochlorothiazide on indices of endothelial damage/dysfunction, angiogenesis and tissue factor in essential hypertension.
    Chung NA; Beevers DG; Lip G
    Blood Press; 2004; 13(3):183-9. PubMed ID: 15223728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of angiotensin II receptor blockade-based therapy with losartan on left ventricular hypertrophy and geometry in previously treated hypertensive patients.
    Cuspidi C; Meani S; Valerio C; Fusi V; Sala C; Maisaidi M; Zanchetti A
    Blood Press; 2006; 15(2):107-15. PubMed ID: 16754274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin C improves endothelial function of epicardial coronary arteries in patients with hypercholesterolaemia or essential hypertension--assessed by cold pressor testing.
    Jeserich M; Schindler T; Olschewski M; Unmüssig M; Just H; Solzbach U
    Eur Heart J; 1999 Nov; 20(22):1676-80. PubMed ID: 10543931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular changes in hypertension in response to drug treatment: Effects of angiotensin receptor blockers.
    Schiffrin EL
    Can J Cardiol; 2002 May; 18 Suppl A():15A-18A. PubMed ID: 12045789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of losartan, compared with atenolol, on endothelial function and oxidative stress in patients with type 2 diabetes and hypertension.
    Flammer AJ; Hermann F; Wiesli P; Schwegler B; Chenevard R; Hürlimann D; Sudano I; Gay S; Neidhart M; Riesen W; Ruschitzka F; Lüscher TF; Noll G; Lehmann R
    J Hypertens; 2007 Apr; 25(4):785-91. PubMed ID: 17351370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of losartan on heart rate and blood pressure variability during tilt test and trinitroglycerine vasodilation.
    Pancera P; Presciuttini B; Sansone S; Montagna L; Paluani F; Covi G; Lechi A
    J Hypertens; 1999 Apr; 17(4):513-21. PubMed ID: 10404953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.